Literature DB >> 13129632

Radiation therapy induced changes in male sex hormone levels in rectal cancer patients.

Svein Dueland1, Marianne Grønlie Guren, Dag Rune Olsen, Jan Peter Poulsen, Kjell Magne Tveit.   

Abstract

BACKGROUND AND
PURPOSE: To determine the effect of curative radiation therapy (46-50 Gy) on the sex hormone levels in male rectal cancer patients.
MATERIALS AND METHODS: Twenty-five male rectal cancer patients (mean age 65 years), receiving pelvic radiation therapy (2 Gyx23-25 fractions in 5 weeks) were included. Serum testosterone, FSH and LH were determined before start of treatment, at the 10th and 25th fractions, and 4-6 weeks after completed radiotherapy. The testicular dose was determined by thermoluminescent dosimetry.
RESULTS: Five weeks of radiation therapy (46-50 Gy) resulted in a 100% increase in serum FSH, a 70% increase in LH, and a 25% reduction in testosterone levels. After treatment, 35% of the patients had serum testosterone levels below lower limit of reference. The mean radiation dose to the testicles was 8.4 Gy. A reduction in testosterone values was observed already after a mean dose of 3.3 Gy (10th fraction).
CONCLUSION: Radiation therapy (46-50 Gy) for rectal cancer resulted in a significant increase in serum FSH and LH and a significant decrease in testosterone levels, indicating that sex hormone production is sensitive to radiation exposure in patients with a mean age of 65 years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129632     DOI: 10.1016/s0167-8140(03)00120-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Acute primary testicular failure due to radiotherapy increases risk of severe postoperative adverse events in rectal cancer patients.

Authors:  John Tapper; Stefan Arver; Torbjörn Holm; Matteo Bottai; Mikael Machado; Ravi Jasuja; Anna Martling; Christian Buchli
Journal:  Eur J Surg Oncol       Date:  2019-07-19       Impact factor: 4.424

2.  Testicular radiation dose after multimodal curative therapy for locally advanced rectal cancer. Influence on hormone levels, quality of life, and sexual functioning.

Authors:  S Hennies; H A Wolff; K Jung; M Rave-Fränk; J Gaedcke; M Ghadimi; C F Hess; H Becker; R M Hermann; H Christiansen
Journal:  Strahlenther Onkol       Date:  2012-08-11       Impact factor: 3.621

3.  Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer.

Authors:  Andreana N Holowatyj; Cathy Eng; Mark A Lewis
Journal:  JCO Oncol Pract       Date:  2021-09-23

4.  Recent Publication Trends in Radiotherapy and Male Infertility over Two Decades: A Scientometric Analysis.

Authors:  Shubhadeep Roychoudhury; Anandan Das; Manesh Kumar Panner Selvam; Saptaparna Chakraborty; Petr Slama; Suresh C Sikka; Kavindra Kumar Kesari
Journal:  Front Cell Dev Biol       Date:  2022-05-12

5.  The Long-Term Effect of Intensity Modulated Radiation Therapy for Prostate Cancer on Testosterone Levels.

Authors:  Yutaka Horiguchi; Fumio Tsukuda; Ayato Ogata; Kiichi Hagiwara; Noboru Sakamoto; Yukihiro Hama; Shoji Koga
Journal:  Adv Radiat Oncol       Date:  2021-11-17

6.  131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes.

Authors:  Naoya Hattori; Ajay K Gopal; Andrew T Shields; Darrell R Fisher; Ted Gooley; John M Pagel; Oliver W Press; Joseph G Rajendran
Journal:  Nucl Med Commun       Date:  2012-12       Impact factor: 1.690

7.  Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-Patients.

Authors:  Johannes Rosenbrock; Andrés Vásquez-Torres; Horst Mueller; Karolin Behringer; Matthias Zerth; Eren Celik; Jiaqi Fan; Maike Trommer; Philipp Linde; Michael Fuchs; Peter Borchmann; Andreas Engert; Simone Marnitz; Christian Baues
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.